Lifesaving liver disease medicines

Our mission

Versantis develops a new generation of liver disease therapeutics and diagnostics.

We are committed to the translation of life-saving therapies for acute hepatic diseases, where the medical need is dramatically high.

A life-saving therapy

Versantis’ lead product candidate, VS-01, is the first treatment for acute-on-chronic liver failure (ACLF), a life-threatening condition of high unmet medical need. The mortality of ACLF patients is alarming due to multi-organ failures resulting in dangerous accumulations of toxins in the blood. The versatile mechanism of action of VS-01 can simultaneously support the affected organs (liver, kidneys, brain), encourage liver regeneration, and save patients’ lives.

discover the full potential of our pipeline...

Awards and supports



Versantis AG
c/o ETH Zurich
Otto-Stern-Weg 7, HPL D16.2
8093 Zurich


Copyright © 2017
Versantis AG